# A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-cost-effectiveness-analysis-of-patiromer-in-the-uk-evaluation-of-hyperkalaemia/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas Ward,Ruth D. Lewis,Tray Brown,Garth Baxter,Antonio Ramírez de Arellano |
| Citations | 7 |
| DOI | 10.1186/s12882-023-03088-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmcnephrol.biomedcentral.com/counter/pdf/10.1186/s12882-023-03088-3 |
| OpenAlex ID | https://openalex.org/W4323652806 |
| PMID | 36890464 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Garth Baxter](https://scholariq.org/researchers/garth-baxter/)

## Paper journal

- [BMC Nephrology](https://scholariq.org/journals/bmc-nephrology/)

## Paper primary topic

- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)

## Paper topics

- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Electrolyte and hormonal disorders](https://scholariq.org/topics/electrolyte-and-hormonal-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.